Strategies to enhance the therapeutic efficacy of anti-PD-1 antibody, anti-PD-L1 antibody and anti-CTLA-4 antibody in cancer therapy
Article in Journal of Translational Medicine (August 2024)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
From tumor to tolerance: A comprehensive review of immune checkpoint inhibitors and immune-related adverse events
Article in Asia Pacific Allergy (May 2024)
Neoadjuvant systemic therapy for hepatocellular carcinoma
Article in Frontiers in Immunology (March 2024)